|Date:||November 16, 2017 | 9:00 am – 5:00 pm
November 17, 2017 | 9:00 am – 3:00 pm
|Location:||The Menger Hotel
204 Alamo Plaza
San Antonio, TX 78205
Click here to register.
» Poster size: 36″ x 36″ or 36″ x 48″ or 36″ x 54″
» Must have at least two (2) authors
» Abstract limited to 250 words maximum
» May use either results or methodology
November 4, 2017
November 11, 2017
Dr. Bishai is interested in the molecular pathogenesis of tuberculosis. A theme of his research has been to assess mycobacterial genes important in gene regulation. Other active interests include cell division in mycobacteria and the pathogenesis of caseation and cavitation. His research program goals are first to better understand tuberculosis pathogenesis, and then to employ this understanding towards improved drugs, vaccines, and diagnostics.
Dr. Bishai received his Ph.D. and his M.D. from Harvard Medical School.
Dr. Damon currently is the CDC Incident Manager for the Ebola 2014 response. Prior to this role, she served as the chief of DHCPP’s Poxvirus and Rabies Branch. Dr. Damon is also a Clinical Assistant Professor at Emory University in Atlanta and is the director of the WHO Collaborating Centre for Smallpox and Other Poxvirus Infections.
Dr. Damon received her M.D. and Ph.D. in Biomedical Sciences from the University of Connecticut.
An internationally recognized expert on hantaviruses and hemorrhagic fever with renal syndrome, Dr. Schmaljohn uses molecular biology tools to develop and test vaccines for a range of viruses. Her lab works on two types of vaccines: those that protect against medical infectious diseases and those that defend against agents that could be used as weapons in biological warfare.
Dr. Schmaljohn received her Ph.D. from Colorado State University.
Dr. Sun has been studying signal transduction in the immune and inflammatory responses for more than twenty years, with a major focus on the regulation of inflammatory T-cell activation and differentiation. An important part of his lab’s ongoing research is to dissect the ubiquitin-dependent signaling pathways in the regulation of inflammatory T cell function in inflammation and inflammation-associated cancer.
Dr. Sun received his Ph.D. in Microbiology from Stockholm University.
Dr. Wu’s current research includes dysregulation of immunity and inflammation, Immunotherapy and immune intervention, and microbial pathogenesis and commensalism. These research areas are dedicated to the understanding of how commensal bacteria influence the inflammatory and immune response mediated by autoimmune disease. The goal of this work is focused on exploring the link between gut microbiota, mucosal immunity, and autoimmune arthritis.
Dr. Wu received her Ph.D. from the University of Kentucky.